# A Double-Blinded, Randomized Placebo Controlled Pilot Study Comparing the Efficacy and Safety of IncobotulinumtoxinA Versus Saline Injections to the Cheek Region in Patients With Rosacea

> **NCT01614743** · PHASE2 · COMPLETED · sponsor: **DeNova Research** · enrollment: 9 (actual)

## Conditions studied

- Rosacea

## Interventions

- **DRUG:** IncobotulinumtoxinA
- **DRUG:** Bacteriostatic saline

## Key facts

- **NCT ID:** NCT01614743
- **Lead sponsor:** DeNova Research
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06
- **Primary completion:** 2013-11
- **Final completion:** 2013-11
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2020-10-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01614743

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01614743, "A Double-Blinded, Randomized Placebo Controlled Pilot Study Comparing the Efficacy and Safety of IncobotulinumtoxinA Versus Saline Injections to the Cheek Region in Patients With Rosacea". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01614743. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*